New PET Scan for Detecting Multiple Cancer Types
Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study tests a new type of PET scan (a specialized imaging test) that may better detect certain cancers by looking for a specific marker found on many tumor types. The scan uses a new tracer called 18F-T2 to help doctors see cancer more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have been diagnosed with or suspected to have one of the eligible cancer types (kidney, bladder, colon, cervix, ovary, head and neck, liver, lung, breast, pancreas, uterus, or related conditions)
- You must be able to understand the study and follow all instructions
- You must sign an informed consent form agreeing to participate
- You cannot be pregnant or breastfeeding
- You cannot have serious health conditions (psychiatric, infectious, autoimmune, or metabolic) that would interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial tests a new type of PET scan that uses a special antibody to find a marker called Trop2 on many common solid tumors. It may help doctors see tumors more clearly without needing a biopsy.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.
This trial uses a special PET/CT scan that targets a protein on some cancer cells to help detect and evaluate malignant tumors. It may help doctors better map tumors before any cancer treatment starts.
This study tests a new PET scanner that may give clearer or more detailed pictures of cancer. It is for people who are already scheduled for a PET-CT scan at Memorial Sloan Kettering, and it could help doctors see cancer more precisely.
Hear when a new Clear Cell Renal Cell Cancer (ccRCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.